5M3X
Crystal structure of human angiotensin I-deleted angiotensinogen
5M3X の概要
エントリーDOI | 10.2210/pdb5m3x/pdb |
分子名称 | Angiotensinogen (2 entities in total) |
機能のキーワード | spent angiotensinogen, angiotensin i-deleted angiotensinogen, serine protease inhibitor |
由来する生物種 | Homo sapiens (Human) |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 98732.35 |
構造登録者 | |
主引用文献 | Yan, Y.,Zhou, A.,Carrell, R.W.,Read, R.J. Structural basis for the specificity of renin-mediated angiotensinogen cleavage. J. Biol. Chem., 294:2353-2364, 2019 Cited by PubMed Abstract: The renin-angiotensin cascade is a hormone system that regulates blood pressure and fluid balance. Renin-mediated cleavage of the angiotensin I peptide from the N terminus of angiotensinogen (AGT) is the rate-limiting step of this cascade; however, the detailed molecular mechanism underlying this step is unclear. Here, we solved the crystal structures of glycosylated human AGT (2.30 Å resolution), its encounter complex with renin (2.55 Å), AGT cleaved in its reactive center loop (RCL; 2.97 Å), and spent AGT from which the N-terminal angiotensin peptide was removed (2.63 Å). These structures revealed that AGT undergoes profound conformational changes and binds renin through a tail-into-mouth allosteric mechanism that inserts the N terminus into a pocket equivalent to a hormone-binding site on other serpins. These changes fully extended the N-terminal tail, with the scissile bond for angiotensin release docked in renin's active site. Insertion of the N terminus into this pocket accompanied a complete unwinding of helix H of AGT, which, in turn, formed key interactions with renin in the complementary binding interface. Mutagenesis and kinetic analyses confirmed that renin-mediated production of angiotensin I is controlled by interactions of amino acid residues and glycan components outside renin's active-site cleft. Our findings indicate that AGT adapts unique serpin features for hormone delivery and binds renin through concerted movements in the N-terminal tail and in its main body to modulate angiotensin release. These insights provide a structural basis for the development of agents that attenuate angiotensin release by targeting AGT's hormone binding pocket. PubMed: 30563843DOI: 10.1074/jbc.RA118.006608 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.63 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード